Stock data

Akums Drugs and Pharma L share price

AKUMS on NSE · data as of 16 Oct 2026

₹731.45Close · −2.45%
₹838.8052-week high · 23 Sept 2026
₹409.3052-week low · 21 Jan 2026
−12.8%from 52-week high
+63.9%1-year return
₹19.2 cravg daily turnover (20 days)

Akums Drugs and Pharma L closed at ₹731.45 on 16 Oct 2026 (−2.45% on the day). It is 12.8% below its 52-week high of ₹838.80 (23 Sept 2026) and 78.7% above its 52-week low of ₹409.30 (21 Jan 2026). The stock has outperformed the Nifty 50 over the past year (+63.9% vs -8.5%). It is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 29 (oversold zone).

Where the price sits

52W low ₹409.3052W high ₹838.80

Last 12 months

Weekly closing prices, adjusted for splits and bonus issues.

Returns vs Nifty 50

PeriodAKUMSNifty 50Difference
1 week−2.7%+2.8%−5.5 pts
1 month−5.3%−0.3%−5.0 pts
3 months+10.0%−4.9%+14.9 pts
6 months+32.8%−4.3%+37.1 pts
1 year+63.9%−8.5%+72.4 pts

Trend and activity

  • 50-day average: ₹768.96 (price below)
  • 200-day average: ₹591.27 (price above)
  • RSI (14 days): 29
  • Turnover on 16 Oct 2026: ₹11.1 cr (0.6x the 20-day average volume)

New to these terms? See 52-week high, moving average and RSI.

Quick answers

What is the 52-week high of Akums Drugs and Pharma L?

The 52-week high of Akums Drugs and Pharma L (AKUMS) is ₹838.80, reached on 23 Sept 2026. The 52-week low is ₹409.30, on 21 Jan 2026 (NSE, as of 16 Oct 2026).

How has Akums Drugs and Pharma L performed in the last year?

Over the last year the share price has moved +63.9%, compared with -8.5% for the Nifty 50 (as of 16 Oct 2026). Past returns do not predict future returns.

Is Akums Drugs and Pharma L in an uptrend?

As of 16 Oct 2026, Akums Drugs and Pharma L is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 29 (oversold zone). Trend describes the past, not what happens next.

Price facts only, refreshed every trading day. Not a recommendation to buy or sell. Education only. Not investment advice. All stocks · Today's stock lists